Traws Pharma, Inc. — Director's Dealing 2016

Dec 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2016-12-15

Reporting Person: Guerin Mark Patrick (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-15	Stock Option (right to purchase)	$2.65	A	5587	Acquired	2026-12-15	Common Stock (5587)	Direct

Footnotes

F1: These options vest over three years in 36 equal monthly installments.